Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 149 , 112918
It can inhibit the growth of medulloblastoma cells at a low concentration
It says it will remove products from the market if they claim to treat or change how the body works if they are not licensed under the Human Medicines Regulations Act 2012, and that it strongly advises against purchasing and using unauthorised medicinal products - "particularly those promoted on social media".
BPC-157 (Body Protection Compound-157) is a short, 15-amino acid synthetic peptide widely used in preclinical research to examine tissue-response patterns to experimentally induced stress or injury in controlled laboratory conditions
This is the autoimmune cascade
They report that transcript abundance changed, which is not the same claim as that a function changed, and the gap between those two statements is where most over-reading of this compound happens